Provided by Tiger Fintech (Singapore) Pte. Ltd.

SciSparc Ltd.

0.2788
-0.0006-0.21%
Post-market: 0.28490.0061+2.19%18:27 EDT
Volume:59.27K
Turnover:16.46K
Market Cap:3.02M
PE:-0.22
High:0.2831
Open:0.2788
Low:0.2726
Close:0.2794
Loading ...

Scisparc Ltd: Secures Favorable Settlement in Lawsuit Filed in Feb 2022 Against Six Former Directors

THOMSON REUTERS
·
18 Feb

Scisparc Ltd: as Part of Settlement, Co Is Entitled to $411,000 Payment From Defendants for Full Dismissal by Co of Alleged Claims

THOMSON REUTERS
·
18 Feb

SciSparc Secures Favorable Settlement in Lawsuit It Filed, Receiving Cash Compensation and a Full Release from All Commitments, Royalties, and Allegations Asserted Against It on Claimed Core Technology

GlobeNewswire
·
18 Feb

Scisparc-Clearmind Collaboration Leads to Publication of Patent for Binge Behaviour Combination Treatment in Mexico

THOMSON REUTERS
·
04 Feb

SciSparc-Clearmind Collaboration Leads to Publication of Patent for Binge Behaviour Combination Treatment in Mexico

GlobeNewswire
·
04 Feb

Clearmind Medicine Announces Publication of Patent for Binge Behavior Psychedelic Combination Treatment in Mexico

GlobeNewswire
·
04 Feb

SciSparc Gets 180-Day Nasdaq Extension to Regain Compliance With Minimum Bid Price Rule

MT Newswires Live
·
16 Jan

SciSparc granted 180-day extension to regain Nasdaq compliance

TIPRANKS
·
15 Jan

Scisparc Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Requirement

THOMSON REUTERS
·
15 Jan

SciSparc Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement

GlobeNewswire
·
15 Jan

SciSparc: AutoMax Enters the Direct Import Market with a $13 Million First Shipment of JAC Electric Vehicles

GlobeNewswire
·
13 Jan

SciSparc says MitoCareX expands research to pancreatic cancer

TipRanks
·
08 Jan

Scisparc: Mitocarex Bio Expands Research to Pancreatic Cancer Following Initial in-Vitro Positive Results

THOMSON REUTERS
·
07 Jan

SciSparc: MitoCareX Bio Expands Research to Pancreatic Cancer Following Initial In-Vitro Positive Results

GlobeNewswire
·
07 Jan

Top Midday Gainers

MT Newswires Live
·
07 Jan

Why Is Psychedelic-SciSparc Stock Trading Higher On Monday?

Benzinga
·
07 Jan

Sector Update: Health Care Stocks Edge Higher Premarket Monday

MT Newswires Live
·
06 Jan

SciSparc Says Clearmind Medicine Files European Patent Application for Binge Behavior Psychedelic Combination Treatment

MT Newswires Live
·
06 Jan

BRIEF-Scisparc-Clearmind Medicine Collaboration Announces The Publication Of European Patent Application For Binge Behavior Psychedelic Combination Treatment

Reuters
·
06 Jan

Scisparc-Clearmind Medicine Collaboration Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment

THOMSON REUTERS
·
06 Jan